Sigma-Aldrich Corp.

NAS : SIAL
Pharmaceuticals
St. Louis MO
IW Best50N/A
2012 Revenue (US$ Millions)$2,623
2011 Revenue (US$ Millions)$2,505
Revenue Growth (%)4.71%
Net Income (US$ Millions)$460
Common Shares Outstanding (Millions)$120
Earnings Per Share (US$)$3.77
Total Equity (US$ Millions)$2,546
Profit Growth (%)0.66
Profit Margin (%)17.54%
Return On Equity (%)20.92%
Long Term Debt (US$ Millions)$300
Debt To Equity Ratio (%)0.12%
Market Capitalization (US$ Millions)$8,830
Total Assets (US$ Millions)$3,820
Return on Assets (%)14.02
Current Assets (US$ Millions)$1,929
Inventories (US$ Millions)$722
Current Liabilities (US$ Millions)$701
Cost of Goods Sold (US$ Millions)$1,276
Asset Turnover0.69
Inventory Turnover1.84